Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAMK1D | Q8IU85 | 15/20 | 0.46 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.45 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.44 |
| ▸ | JAK2 | O60674 | 1/20 | 0.43 |
| ▸ | JAK1 | P23458 | 1/20 | 0.43 |
| ▸ | BTK | Q06187 | 1/20 | 0.41 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.40 |
| ▸ | PIP5K1C | O60331 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | RIPK4 | P57078 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | MAP2K5 | Q13163 | 1/20 | 0.40 |
| ▸ | CAMK1 | Q14012 | 1/20 | 0.40 |
| ▸ | MAP3K11 | Q16584 | 1/20 | 0.40 |
| ▸ | PNCK | Q6P2M8 | 1/20 | 0.40 |
| ▸ | CAMK1G | Q96NX5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30751577 | 0.89 | CAMK1D (0.48) | CAMK1DSTK17APDE4BJAK2JAK1 | |
| SCHEMBL31673049 | 0.88 | CAMK1D (0.59) | CAMK1DPDE4BJAK2JAK1BTK | |
| SCHEMBL31673012 | 0.88 | CAMK1D (0.46) | CAMK1DSTK17APDE4BJAK2JAK1 | |
| SCHEMBL31673014 | 0.87 | STK17A (0.46) | CAMK1DSTK17APDE4BJAK2JAK1 | |
| Hydrochloric Acid SCHEMBL31673031 | 0.86 | STK17A (0.46) | CAMK1DSTK17APDE4BJAK2JAK1 | |
| SCHEMBL30751514 | 0.83 | MAPT (0.53) | CAMK1DSTK17APDE4B | |
| SCHEMBL31673029 | 0.81 | CAMK1D (0.53) | CAMK1DPDE4BJAK2JAK1BTK | |
| Hydrochloric Acid SCHEMBL31673023 | 0.80 | CAMK1D (0.53) | CAMK1DPDE4BJAK2JAK1BTK | |
| SCHEMBL30751519 | 0.79 | SYK (0.56) | CAMK1DPDE4B | |
| SCHEMBL31673036 | 0.79 | SYK (0.52) | CAMK1DPDE4BJAK2JAK1BTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250257051-A1 | SUBSTITUTED PYRIMIDINE COMPOUNDS AS TYK2 INHIBITORS | 1910 GENETICS INC (US) | 2025-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250257051-A1 | SUBSTITUTED PYRIMIDINE COMPOUNDS AS TYK2 INHIBITORS | TYK2, PDXK, JAK1 | CAMK1D 667/4885STK17A 54/4885PDE4B 4049/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.